• OPEN AN ACCOUNT
Indian Indices
Nifty
25,355.25 -120.85
(-0.47%)
Sensex
83,190.28 -345.80
( -0.41%)
Bank Nifty
56,956.00 -257.55
( -0.45%)
Nifty IT
38,376.65 -304.20
( -0.79%)
Global Indices
Nasdaq
44,477.29 215.52
(0.49%)
Dow Jones
6,283.97 37.45
(0.60%)
Hang Seng
39,601.95 -219.33
(-0.55%)
Nikkei 225
8,975.66 108.64
(1.23%)
Forex
USD-INR
85.73 -0.06
(-0.07%)
EUR-INR
100.55 -0.15
(-0.15%)
GBP-INR
116.58 -0.23
(-0.19%)
JPY-INR
0.59 0.00
(-0.73%)

EQUITY - MARKET SCREENER

Balkrishna Industries Ltd
Industry :  Tyres
BSE Code
ISIN Demat
Book Value()
502355
INE787D01026
537.1396842
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BALKRISIND
33.94
50660.7
EPS(TTM)
Face Value()
Div & Yield %
77.22
2
0.61
 

moil ltd
Sun Pharma updates on US FDA inspection
Jun 14,2025
Sun Pharmaceutical Industries has informed that the US FDA conducted a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries Limited's Halol facility (Gujarat, India) from 02 June to 13 June 2025. At the conclusion of the inspection, the US FDA issued a Form-483, with 8 observations.